Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine in relapsed/refractory ALL (pediatric and young adult)
CTR20140060Phase 2Completed
- Sponsor
- Hangzhou Rongli Pharmaceutical Technology
- Start
- May 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute lymphoblastic leukemia (ALL), sponsored by Hangzhou Rongli Pharmaceutical Technology. Started May 2014; status: completed.
02
Drugs
clofarabine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on CTR20140060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140060.